Page last updated: 2024-09-04

febuxostat and flunisolide

febuxostat has been researched along with flunisolide in 1 studies

Compound Research Comparison

Studies
(febuxostat)
Trials
(febuxostat)
Recent Studies (post-2010)
(febuxostat)
Studies
(flunisolide)
Trials
(flunisolide)
Recent Studies (post-2010) (flunisolide)
81813371028612532

Protein Interaction Comparison

ProteinTaxonomyfebuxostat (IC50)flunisolide (IC50)
Glucocorticoid receptorHomo sapiens (human)0.0053
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)0.0053
Glycine receptor subunit betaRattus norvegicus (Norway rat)0.0053
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)0.0053
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)0.0053

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for febuxostat and flunisolide

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013